Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution
2010; Elsevier BV; Volume: 116; Issue: 16 Linguagem: Inglês
10.1182/blood-2010-05-286856
ISSN1528-0020
AutoresRonjon Chakraverty, Guillermo Ortí, Sy Ha, Jun Shen, Adele K. Fielding, Panagiotis Kottaridis, Donald Milligan, Matthew Collin, Charles Crawley, Peter Johnson, Andrew Clark, Anne Parker, Adrian Bloor, Ruth Pettengell, John A. Snowden, Andrew R. Pettitt, Richard E. Clark, G Hale, Karl S. Peggs, Kirsty Thomson, Emma Morris, Stephen Mackinnon,
Tópico(s)CAR-T cell therapy research
Referência(s)